| Previous Close | 0.0002 |
| Open | 0.0001 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0001 - 0.0002 |
| 52 Week Range | 0.0000 - 0.4998 |
| Volume | 6,755,437 |
| Avg. Volume | 104,893,422 |
| Market Cap | 523,378 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1010 |
| Earnings Date | Sep. 09, 2020 - Sep. 10, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Simlatus Chairman Richard Hylen Announces New Contract With Cannabis Distribution Partner Valued At $3M
San Francisco, California, July 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), announces today that the company has contracted to build its cannabis extraction systems for one of the west coast premier cannabis technology firms. About Simlatus: The company operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry.
- GlobeNewswire
Simlatus Chairman Announces Company Subsidiary, Proscere Bioscience, Obtains $20 Mil in Initial Orders of Its CBD Coldwater Extraction System; Moves to Complete Its Manufacturing
San Francisco, CA, June 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), announces today that its Chairman Richard Hylen is updating shareholders regarding the company's subsidiary, Proscere Bioscience, and the overall financial future of the company including obtaining initial orders totaling $20Mil for its CBD coldwater extraction system. This allows their global operation to produce more efficiently, with less waste and save money.
- GlobeNewswire
Proscere Bioscience $200M Revenue Projection CBD Coldwater Extraction Moves Forward
San Francisco, California, May 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), announces today that the company has completed its testing and will move forward with Proscere Bioscience’s CBD coldwater extraction systems and initial $20M in orders. Proscere Bioscience will spearhead the revenue for our company.
